AT-527

Study of AT-527 in Healthy and HCV-Infected Subjects

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Bronchopulmonary PK of AT-527 (R07496998)

Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal

Study of AT-527 in Subjects With Normal and Impaired Renal Function

Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19